Literature DB >> 15139759

Syntheses and characterization of the acyl glucuronide and hydroxy metabolites of diclofenac.

Jane R Kenny1, James L Maggs, Xiaoli Meng, Deborah Sinnott, Stephen E Clarke, B Kevin Park, Andrew V Stachulski.   

Abstract

In humans, metabolism of the commonly used nonsteroidal antiinflammatory drug diclofenac 1 yields principally the 4'-hydroxy 2, 5-hydroxy 3, and acyl glucuronide 4 metabolites. All three metabolites have been implicated in rare idiosyncratic adverse reactions associated with this widely used drug. Therefore, for mechanistic toxicological studies of 1, substantial quantities of 2-4 are required and their syntheses and characterization are described here. Key steps were a convenient two-step preparation of aniline 5 from phenol, efficient and selective 6-iodination of amide 18, and high-yielding Ullmann couplings to generate diarylamines 11 and 21. The acyl glucuronide 4 was obtained by Mitsunobu reaction of 1 (free acid) with allyl glucuronate 23 followed by Pd(0) deprotection, using a modification of a published procedure. We report full characterization of 4 and note that this important metabolite has been made available pure and in quantity for the first time. We report also the metabolic fates of the synthetic metabolites: 2 and 3 were glucuronidated in rats, but only 3 formed glutathione adducts in vivo and by enzymatic synthesis via a quinoneimine intermediate. A previously undescribed glutathione adduct of 3 was obtained by enzymatic synthesis. Compound 4 formed an imine-linked protein conjugate as evinced by sodium cyanoborohydride trapping.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15139759     DOI: 10.1021/jm030891w

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Synthesis of Sterically Hindered Polychlorinated Biphenyl Derivatives.

Authors:  S N Joshi; S M Vyas; M W Duffel; S Parkin; H-J Lehmler
Journal:  Synthesis (Stuttg)       Date:  2011-01-01       Impact factor: 3.157

2.  Preparative microfluidic electrosynthesis of drug metabolites.

Authors:  Romain Stalder; Gregory P Roth
Journal:  ACS Med Chem Lett       Date:  2013-10-01       Impact factor: 4.345

3.  Multidrug Resistance-Associated Protein 3 Plays an Important Role in Protection against Acute Toxicity of Diclofenac.

Authors:  Renato J Scialis; Iván L Csanaky; Michael J Goedken; José E Manautou
Journal:  Drug Metab Dispos       Date:  2015-04-20       Impact factor: 3.922

4.  Mass spectrometric characterization of circulating covalent protein adducts derived from a drug acyl glucuronide metabolite: multiple albumin adductions in diclofenac patients.

Authors:  Thomas G Hammond; Xiaoli Meng; Rosalind E Jenkins; James L Maggs; Anahi Santoyo Castelazo; Sophie L Regan; Stuart N L Bennett; Caroline J Earnshaw; Guruprasad P Aithal; Ira Pande; J Gerry Kenna; Andrew V Stachulski; B Kevin Park; Dominic P Williams
Journal:  J Pharmacol Exp Ther       Date:  2014-06-05       Impact factor: 4.030

5.  Discovery of PF-04620110, a Potent, Selective, and Orally Bioavailable Inhibitor of DGAT-1.

Authors:  Robert L Dow; Jian-Cheng Li; Michael P Pence; E Michael Gibbs; Jennifer L LaPerle; John Litchfield; David W Piotrowski; Michael J Munchhof; Tara B Manion; William J Zavadoski; Gregory S Walker; R Kirk McPherson; Susan Tapley; Eliot Sugarman; Angel Guzman-Perez; Paul DaSilva-Jardine
Journal:  ACS Med Chem Lett       Date:  2011-03-18       Impact factor: 4.345

6.  Role of intestinal cytochrome p450 enzymes in diclofenac-induced toxicity in the small intestine.

Authors:  Yi Zhu; Qing-Yu Zhang
Journal:  J Pharmacol Exp Ther       Date:  2012-08-14       Impact factor: 4.030

7.  Identification and Characterization of Efflux Transporters That Modulate the Subtoxic Disposition of Diclofenac and Its Metabolites.

Authors:  Renato J Scialis; Lauren M Aleksunes; Iván L Csanaky; Curtis D Klaassen; José E Manautou
Journal:  Drug Metab Dispos       Date:  2019-08-09       Impact factor: 3.922

8.  Drug-induced Liver Injury.

Authors:  Stefan David; James P Hamilton
Journal:  US Gastroenterol Hepatol Rev       Date:  2010-01-01

9.  Diclofenac hypersensitivity: antibody responses to the parent drug and relevant metabolites.

Authors:  Andrea Harrer; Roland Lang; Robert Grims; Michaela Braitsch; Thomas Hawranek; Werner Aberer; Lothar Vogel; Walther Schmid; Fatima Ferreira; Martin Himly
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

Review 10.  Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man.

Authors:  Sanja Dragovic; Nico P E Vermeulen; Helga H Gerets; Philip G Hewitt; Magnus Ingelman-Sundberg; B Kevin Park; Satu Juhila; Jan Snoeys; Richard J Weaver
Journal:  Arch Toxicol       Date:  2016-09-22       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.